To further elucidate the specific protein that mediates BET inhibitor-induced sensitization of melanoma cells to sunitinib, we overlapped the downregulated differentially expressed genes after BET inhibitor treatment and after BRD4 silencing (Fig. 5c). This evidence concerns the gene DNER and melanoma.